Erratum for: Legal responses to new psychoactive substances in Europe: countries inside the REITOX network, Norway, and Türkiye.

Ann Ist Super Sanità 2026 | Vol. 62, No. 2: 100-114 DOI: 10.4415/ANN_26_02_02 In the originally published version of this manuscript, an error occurred in the third column of Table 1 (Italy drug scheduling section, page 105) reporting the drug scheduling for Italy. The correct drug scheduling should read: "The scheduling system classifies substances into five Tables: - Table I: substances with highest abuse potential (e.g., heroin, cocaine, amphetamines) - Table II: cannabis products (e.g. marijuana, hashish) - Table III: barbiturates - Table IV: benzodiazepines - Table medicinal products: medicinal products containing narcotic or psychotropic substances" instead of: The scheduling system classifies substances into five Tables: - Table I: substances with high abuse potential and no recognized medical use (e.g., heroin, LSD) - Table II: substances with high abuse potential but with recognized medical use (e.g., morphine, methadone) - Table III: substances with lower abuse potential and recognized medical use (e.g., codeine) - Table IV: preparations containing substances from Tables II and III in combinations that reduce abuse potential Table medicinal products: medicinal products containing narcotic or psychotropic substances in minimal quantities We apologize for this error and any confusion it may have caused.